IP Library Patent Application 11921598
Patent Application
App. No. 11/921,598

Inhibitors of checkpoint kinases

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
11/921,598
Abstract

The instant invention provides for compounds which comprise substituted pyridyl aminothiazoles that inhibit CHK1 activity. The invention also provides for compositions comprising such inhibitory compounds and methods of inhibiting CHK1 activity by administering the compound to a patient in need of treatment of cancer.

Claims (193)

1 . A compound of the Formula A:

wherein:

a is 0 or 1; b is 0 or 1; m is 0, 1, or 2; n is 0, 1, 2, 3, 4 or 5; p is 0, 1, 2, 3, 4 or 5;

Ring A is selected from: (C 3 -C 8 )cycloalkyl, aryl and heterocyclyl;

R 1 is selected from: H, (C═O) a O b C 1 -C 10 alkyl, (C═O) a O b aryl, (C═O) a O b C 2 -C 10 alkenyl, (C═O) a O b C 2 -C 10 alkynyl, CO 2 H, halo, OH, O b C 1 -C 6 perfluoroalkyl, (C═O) a NR 7 R 8 , CN, (C═O) a O b C 3 -C 8 cycloalkyl, S(O) m NR 7 R 8 , S(O) m —(C 1 -C 10 )alkyl, SH and (C═O) a O b heterocyclyl, said alkyl, aryl, alkenyl, alkynyl, cycloalkyl, and heterocyclyl is optionally substituted with one or more substituents selected from R 6 ;

R 2 is selected from: H, (C═O) a O b C 1 -C 10 alkyl, (C═O) a O b aryl, (C═O) a O b C 2 -C 10 alkenyl, (C═O) a O b C 2 -C 10 alkynyl, CO 2 H, Br, I, OH, O b C 1 -C 6 perfluoroalkyl, (C═O) a NR 7 R 8 , CN, (C═O) a O b C 3 -C 8 cycloalkyl, S(O) m NR 7 R 8 , S(O) m —(C 1 -C 10 )alkyl, SH and (C═O) a O b heterocyclyl, said alkyl, aryl, alkenyl, alkynyl, cycloalkyl, and heterocyclyl is optionally substituted with one or more substituents selected from R 6 ;

R 6 is: (C═O) a O b C 1 -C 10 alkyl, (C═O) a O b aryl, C 2 -C 10 alkenyl, C 2 -C 10 alkynyl, (C═O) a O b heterocyclyl, CO 2 H, halo, CN, OH, O b C 1 -C 6 perfluoroalkyl, O a (C═O) b NR 7 R 8 , oxo, CHO, (N═O)R 7 R 8 , S(O) m NR 7 R 8 , S(O) m —(C 1 -C 10 )alkyl, SH or (C═O) a O b C 3 -C 8 cycloalkyl, said alkyl, aryl, alkenyl, alkynyl, heterocyclyl, and cycloalkyl optionally substituted with one or more substituents selected from R 6a ;

R 6a is selected from: (C═O) a O b (C 1 -C 10 )alkyl, O a (C 1 -C 3 )perfluoroalkyl, (C 0 -C 6 )alkylene-S(O) m R a , oxo, OH, halo, CN, (C 2 -C 10 )alkenyl, (C 2 -C 10 )alkynyl, (C 3 -C 6 )cycloalkyl, (C 0 -C 6 )alkylene-aryl, (C═O)heterocyclyl, (C═O)—N(R b ) 2 , (C 0 -C 6 )alkylene-heterocyclyl, (C 0 -C 6 )alkylene-N(R b ) 2 , C(O)R a , (C 0 -C 6 )alkylene-CO 2 R a , C(O)H, and (C 0 -C 6 )alkylene-CO 2 H, said alkyl, alkenyl, alkynyl, cycloalkyl, aryl, and heterocyclyl is optionally substituted with up to three substituents selected from R b , OH, (C 1 -C 6 )alkoxy, halogen, CO 2 H, CN, O(C═O)C 1 -C 6 alkyl, oxo, and N(R b ) 2 ;

R 7 and R 8 are independently selected from: H, (C═O)O b C 1 -C 10 alkyl, (C═O)O b C 3 -C 8 cycloalkyl, (C═O)O b aryl, (C═O)O b heterocyclyl, C 1 -C 10 alkyl, aryl, C 2 -C 10 alkenyl, C 2 -C 10 alkynyl, heterocyclyl, C 3 -C 8 cycloalkyl, S(O) m R a , and (C═O)NR b 2 , said alkyl, cycloalkyl, aryl, heterocylyl, alkenyl, and alkynyl is optionally substituted with one or more substituents selected from R 6a , or R 7 and R 8 can be taken together with the nitrogen to which they are attached to form a monocyclic or bicyclic heterocycle with 3-7 members in each ring and optionally containing, in addition to the nitrogen, one or two additional heteroatoms selected from N, O and S, said monocyclic or bicyclic heterocycle optionally substituted with one or more substituents selected from R 6a ;

R a is H, (C 1 -C 6 )alkyl, (C 3 -C 6 )cycloalkyl, aryl, or heterocyclyl; and

R b is independently H, (C 1 -C 6 )alkyl, aryl, heterocyclyl, (C 3 -C 6 )cycloalkyl, (C═O)OC 1 -C 6 alkyl, (C═O)C 1 -C 6 alkyl or S(O) m R a ;

or a pharmaceutically acceptable salt or a stereoisomer thereof.

2 . The compound according to claim 1 of the Formula B:

wherein:

X is Nor CH; and

all other substituents are as defined in claim 1 ;

or a pharmaceutically acceptable salt or a stereoisomer thereof.

3 . A compound which is selected from:

N-[5-(6-methylpyridin-3-yl)-1,3-thiazol-2-yl]-4-piperazin-1-ylpyridin-2-amine;

4-[4-(2-morpholin-4-yl-2-oxoethyl)piperazin-1-yl]-N-(5-pyrimidin-5-yl-1,3-thiazol-2-yl)pyridin-2-amine;

(4-{2-[(5-pyridin-3-yl-1,3-thiazol-2-yl)amino]pyridin-4-yl}morpholin-2-yl)methanol;

2-({2-[(5-pyrimidin-5-yl-1,3-thiazol-2-yl)amino]pyridin-4-yl}amino)ethanol;

N 4 -propyl-N 2 -(5-pyrimidin-5-yl-1,3-thiazol-2-yl)pyridine-2,4-diamine;

4-[4-(methylsulfonyl)piperazin-1-yl]-N-(5-pyrimidin-5-yl-1,3-thiazol-2-yl)pyridin-2-amine;

N5-(6-methylpyridin-3-yl)-1,3-thiazol-2-yl]-4-[4-(methylsulfonyl)piperazin-1-yl]pyridin-2-amine;

4-(4-acetylpiperazin-1-yl)-N-[5-(6-methylpyridin-3-yl)-1,3-thiazol-2-yl]pyridin-2-amine;

N[5-(6-methylpyridin-3-yl)-1,3-thiazol-2-yl]-4-morpholin-4-ylpyridin-2-amine;

N,N-dimethyl-4-{2-[(5-pyrimidin-5-yl-1,3-thiazol-2-yl)amino]pyridin-4-yl}piperazine-1-sulfonamide;

4-piperazin-1-yl-N-(5-pyrimidin-5-yl-1,3-thiazol-2-yl)pyridin-2-amine;

4-(4-acetylpiperazin-1-yl)-N-(5-pyrimidin-5-yl-1,3-thiazol-2-yl)pyridin-2-amine;

4-morpholin-4-yl-N-(5-pyrimidin-5-yl-1,3-thiazol-2-yl)pyridin-2-amine;

(4-{2-[(5-pyrimidin-5-yl-1,3-thiazol-2-yl)amino]pyridin-4-yl}morpholin-2-yl)methanol;

N 4 -(4-aminobutyl)-N 2 -(5-pyrimidin-5-yl-1,3-thiazol-2-yl)pyridine-2,4-diamine;

N-[5-(2-methylpyrimidin-5-yl)-1,3-thiazol-2-yl]-4-morpholin-4-ylpyridin-2-amine;

N-[5-(2-methylpyrimidin-5-yl)-1,3-thiazol-2-yl]-4-[4-(methylsulfonyl)piperazin-1-yl]pyridin-2-amine;

N-[5-(2-methylpyrimidin-5-yl)-1,3-thiazol-2-yl]-4-piperazin-1-ylpyridin-2-amine;

N-[5-(6-methylpyridin-3-yl)-1,3-thiazol-2-yl]-6-piperazin-1-ylpyridin-2-amine;

6-[4-(aminomethyl)cyclohexyl]-N-(5-pyrimidin-5-yl-1,3-thiazol-2-yl)pyridin-2-amine;

6-(4-acetylpiperazin-1-yl)-N-[5-(6-methylpyridin-3-yl)-1,3-thiazol-2-yl]pyridin-2-amine;

N-[5-(6-methylpyridin-3-yl)-1,3-thiazol-2-yl]-6-[4-(methylsulfonyl)piperazin-1-yl]pyridin-2-amine;

N-[5-(6-methylpyridin-3-yl)-1,3-thiazol-2-yl]-6-morpholin-4-ylpyridin-2-amine;

N-(3-aminopropyl)-N-[5-(6-methylpyridin-3-yl)-1,3-thiazol-2-yl]pyridine-2,6-diamine;

N-[5-(6-methylpyridin-3-yl)-1,3-thiazol-2-yl]-N-(2-pyrrolidin-1-ylethyl)pyridine-2,6-diamine;

6-piperazin-1-yl-N-(5-pyrimidin-5-yl-1,3-thiazol-2-yl)pyridin-2-amine;

N-[5-(2-methylpyrimidin-5-yl)-1,3-thiazol-2-yl]-6-piperazin-1-ylpyridin-2-amine;

N-[5-(6-methylpyridin-3-yl)-1,3-thiazol-2-yl]-4-(morpholin-4-ylmethyl)pyridin-2-amine;

N-[5-(6-methylpyridin-3-yl)-1,3-thiazol-2-yl]-4-{[4-(methylsulfonyl)piperazin-1-yl]methyl}pyridin-2-amine;

N-[5-(6-methylpyridin-3-yl)-1,3-thiazol-2-yl]-5-(morpholin-4-ylmethyl)pyridin-2-amine;

N-[5-(6-methylpyridin-3-yl)-1,3-thiazol-2-yl]-5-{[4-(methylsulfonyl)piperazin-1-yl]methyl}pyridin-2-amine;

N-{5-[5-(1-methyl-1H-pyrazol-4-yl)pyridin-3-yl]-1,3-thiazol-2-yl}-4-morpholin-4-ylpyridin-2-amine;

N-[5-(5-bromopyridin-3-yl)-1,3-thiazol-2-yl]-4-piperazin-1-ylpyridin-2-amine;

4-(2-{[5-(5-bromopyridin-3-yl)-1,3-thiazol-2-yl]amino}pyridin-4-yl)-N,N-dimethylpiperazine-1-carboxamide;

4-morpholin-4-yl-N-{5-[5-(1H-pyrazol-4-yl)pyridin-3-yl]-1,3-thiazol-2-yl}pyridin-2-amine;

N-{5-[5-(3,5-dimethylisoxazol-4-yl)pyridin-3-yl]-1,3-thiazol-2-yl}-4-morpholin-4-ylpyridin-2-amine;

N-[5-(3,3′-bipyridin-5-yl)-1,3-thiazol-2-yl]-4-morpholin-4-ylpyridin-2-amine;

4-morpholin-4-yl-N-[5-(5-pyrimidin-5-ylpyridin-3-yl)-1,3-thiazol-2-yl]pyridin-2-amine;

N-[5-(2′-methoxy-3,3′-bipyridin-5-yl)-1,3-thiazol-2-yl]-4-morpholin-4-ylpyridin-2-amine;

N-[5-(6′-methoxy-3,3′-bipyridin-5-yl)-1,3-thiazol-2-yl]-4-morpholin-4-ylpyridin-2-amine;

N-{5-[5-(2-methoxypyrimidin-5-yl)pyridin-3-yl]-1,3-thiazol-2-yl}-4-morpholin-4-ylpyridin-2-amine;

4-piperazin-1-yl-N-{5-[5-(1H-pyrazol-4-yl)pyridin-3-yl]-1,3-thiazol-2-yl}pyridin-2-amine;

N-{5-[5-(1-methyl-1H-pyrazol-4-yl)pyridin-3-yl]-1,3-thiazol-2-yl}-4-piperazin-1-ylpyridin-2-amine;

N-[5-(3,3′-bipyridin-5-yl)-1,3-thiazol-2-yl]-4-piperazin-1-ylpyridin-2-amine;

N-[5-(5-isothiazol-4-ylpyridin-3-yl)-1,3-thiazol-2-yl]-4-piperazin-1-ylpyridin-2-amine;

N-[5-(6′-fluoro-3,3′-bipyridin-5-yl)-1,3-thiazol-2-yl]-4-piperazin-1-ylpyridin-2-amine;

N-methyl-5′-{2-[(4-piperazin-1-ylpyridin-2-yl)amino]-1,3-thiazol-5-yl}-3,3′-bipyridin-6-amine;

N-ethyl-5′-{2-[(4-piperazin-1-ylpyridin-2-yl)amino]-1,3-thiazol-5-yl}-3,3′-bipyridin-6-amine;

N-{5-[5-(1-methyl-1H-pyrazol-4-yl)pyridin-3-yl]-1,3-thiazol-2-yl}-4-piperidin-1-ylpyridin-2-amine;

N-[2-(3-aminopropoxy)-5-chlorophenyl]-5-pyrimidin-5-yl-1,3-thiazol-2-amine;

N-[2-(3-aminopropoxy)-5-chlorophenyl]-5-(5-bromopyridin-3-yl)-1,3-thiazol-2-amine;

N-[5-(3-bromophenyl)-1,3-thiazol-2-yl]-4-morpholin-4-ylpyridin-2-amine;

N-[5-(3-bromophenyl)-1,3-thiazol-2-yl]-4-piperazin-1-ylpyridin-2-amine;

5-{2-[(4-morpholin-4-ylpyridin-2-yl)amino]-1,3-thiazol-5-yl}nicotinamide;

5-{2-[(4-piperazin-1-ylpyridin-2-yl)amino]-1,3-thiazol-5-yl}nicotinonitrile;

5-{2-[(4-piperazin-1-ylpyridin-2-yl)amino]-1,3-thiazol-5-yl}nicotinamide;

5-{2-[(4-piperazin-1-ylpyridin-2-yl)amino]-1,3-thiazol-5-yl}nicotinic acid;

N-(5-{2-[(4-morpholin-4-ylpyridin-2-yl)amino]-1,3-thiazol-5-yl}pyridin-3-yl)ethane-1,2-diamine;

N-(5-{2-[(4-morpholin-4-ylpyridin-2-yl)amino]-1,3-thiazol-5-yl}pyridin-3-yl)propane-1,3-diamine;

2-[(5-{2-[(4-morpholin-4-ylpyridin-2-yl)amino]-1,3-thiazol-5-yl}pyridin-3-yl)amino]ethanol;

4-morpholin-4-yl-N-{5-[5-(1H-1,2,3-triazol-1-yl)pyridin-3-yl]-1,3-thiazol-2-yl}pyridin-2-amine;

4-morpholin-4-yl-N-{5-[5-(2H-1,2,3-triazol-2-yl)pyridin-3-yl]-1,3-thiazol-2-yl}pyridin-2-amine;

N-(3-{2-[(4-morpholin-4-ylpyridin-2-yl)amino]-1,3-thiazol-5-yl}phenyl)ethane-1,2-diamine;

N-(3-{2-[(4-morpholin-4-ylpyridin-2-yl)amino]-1,3-thiazol-5-yl}phenyl)propane-1,3-diamine;

N,N-dimethyl-N′-(3-{2-[(4-morpholin-4-ylpyridin-2-yl)amino]-1,3-thiazol-5-yl}phenyl)ethane-1,2-diamine;

5-(2-{[4-(4-acetylpiperazin-1-yl)pyridin-2-yl]amino}-1,3-thiazol-5-yl)-N-(2-aminoethyl)nicotinamide;

5-[2-({4-[4-(methylsulfonyl)piperazin-1-yl]pyridin-2-yl}amino)-1,3-thiazol-5-yl]nicotinic acid;

5-(2-{[4-(4-acetylpiperazin-1-yl)pyridin-2-yl]amino}-1,3-thiazol-5-yl)-N-methylnicotinamide;

N-methyl-5-[2-({4-[4-(methylsulfonyl)piperazin-1-yl]pyridin-2-yl}amino)-1,3-thiazol-5-yl]nicotinamide;

N-(2-aminoethyl)-5-[2-({4-[4-(methylsulfonyl)piperazin-1-yl]pyridin-2-yl}amino)-1,3-thiazol-5-yl]nicotinamide;

N-methyl-5-{2-[(4-piperazin-1-ylpyridin-2-yl)amino]-1,3-thiazol-5-yl}nicotinamide;

N-(2-aminoethyl)-5-{2-[(4-piperazin-1-ylpyridin-2-yl)amino]-1,3-thiazol-5-yl}nicotinamide;

5-(2-{[4-(4-fluoropiperidin-1-yl)pyridin-2-yl]amino}-1,3-thiazol-5-yl)nicotinic acid;

5-(2-{[4-(4-fluoropiperidin-1-yl)pyridin-2-yl]amino}-1,3-thiazol-5-yl)-N-methylnicotinamide;

N-(2-aminoethyl)-5-(2-{[4-(4-fluoropiperidin-1-yl)pyridin-2-yl]amino}-1,3-thiazol-5-yl)nicotinamide;

5-{2-[(4-piperidin-1-ylpyridin-2-yl)amino]-1,3-thiazol-5-yl}nicotinic acid;

N-methyl-5-{2-[(4-piperidin-1-ylpyridin-2-yl)amino]-1,3-thiazol-5-yl}nicotinamide;

N-[5-(3-bromophenyl)-1,3-thiazol-2-yl]-4-chloropyridin-2-amine;

5-{2-[(4-chloropyridin-2-yl)amino]-1,3-thiazol-5-yl}-N-(2,2,2-trifluoroethyl)nicotinamide;

5-(2-{[4-(4-hydroxypiperidin-1-yl)pyridin-2-yl]amino}-1,3-thiazol-5-yl)-N-(2,2,2-trifluoroethyl)nicotinamide;

1-(2-{[5-(5-{[(2,2,2-trifluoroethyl)amino]carbonyl}pyridin-3-yl)-1,3-thiazol-2-yl]amino}pyridin-4-yl)piperidin-4-ylmethanesulfonate;

3-{2-[(4-chloropyridin-2-yl)amino]-1,3-thiazol-5-yl}benzoic acid;

3-(2-{[4-(4,4-difluoropiperidin-1-yl)pyridin-2-yl]amino}-1,3-thiazol-5-yl)benzoic acid;

N-(2-aminoethyl)-3-(2-{[4-(4,4-difluoropiperidin-1-yl)pyridin-2-yl]amino}-1,3-thiazol-5-yl)benzamide;

5-{2-[(4-morpholin-4-ylpyridin-2-yl)amino]-1,3-thiazol-5-yl}-N-(2,2,2-trifluoroethyl)nicotinamide;

N-methyl-5-{2-[(4-morpholin-4-ylpyridin-2-yl)amino]-1,3-thiazol-5-yl}nicotinamide;

N-(2-aminoethyl)-5-{2-[(4-morpholin-4-ylpyridin-2-yl)amino]-1,3-thiazol-5-yl}nicotinamide;

N-(5-methyl-1,3-thiazol-2-yl)-5-{2-[(4-morpholin-4-ylpyridin-2-yl)amino]-1,3-thiazol-5-yl}nicotinamide;

5-{2-[(4-morpholin-4-ylpyridin-2-yl)amino]-1,3-thiazol-5-yl}-N-1,3,4-thiadiazol-2-ylnicotinamide;

N-ethyl-5-{2-[(4-morpholin-4-ylpyridin-2-yl)amino]-1,3-thiazol-5-yl}nicotinamide;

N-(2-acetamidyl)-5-{2-[(4-morpholin-4-ylpyridin-2-yl)amino]-1,3-thiazol-5-yl}nicotinamide;

N(3-aminopropyl)-5-{2-[(4-morpholin-4-ylpyridin-2-yl)amino]-1,3-thiazol-5-yl}nicotinamide;

N-cyclopropyl-5-{2-[(4-morpholin-4-ylpyridin-2-yl)amino]-1,3-thiazol-5-yl}nicotinamide;

N-(2-hydroxyethyl)-5-{2-[(4-morpholin-4-ylpyridin-2-yl)amino]-1,3-thiazol-5-yl}nicotinamide;

N-[2-(methylamino)ethyl]-5-{2-[(4-morpholin-4-ylpyridin-2-yl)amino]-1,3-thiazol-5-yl}nicotinamide;

5-(2-{[4-(morpholin-4-ylmethyl)pyridin-2-yl]amino}-1,3-thiazol-5-yl)nicotinic acid;

N-(2-aminoethyl)-5-(2-{[4-(morpholin-4-ylmethyl)pyridin-2-yl]amino}-1,3-thiazol-5-yl)nicotinamide;

5-(2-{[4-(morpholin-4-ylmethyl)pyridin-2-yl]amino}-1,3-thiazol-5-yl)-N-prop-2-yn-1-ylnicotinamide;

5-(2-{[4-(4-glycoloylpiperazin-1-yl)pyridin-2-yl]amino}-1,3-thiazol-5-yl)-N-(2,2,2-trifluoroethyl)nicotinamide;

5-(2-{[4-(3,3-difluoroazetidin-1-yl)pyridin-2-yl]amino}-1,3-thiazol-5-yl)-N-(2,2,2-trifluoroethyl)nicotinamide;

N-(2-aminoethyl)-5-(2-{[4-(3,3-difluoroazetidin-1-yl)pyridin-2-yl]amino}-1,3-thiazol-5-yl)nicotinamide;

3-carboxy-5-(2-{[4-(3,3-difluoroazetidin-1-yl)pyridinium-2-yl]amino}-1,3-thiazol-5-yl)pyridinium;

5-(2-{[4-(4,4-difluoropiperidin-1-yl)pyridin-2-yl]amino}-1,3-thiazol-5-yl)nicotinic acid;

5-[2-({4-[4-(methylsulfonyl)piperazin-1-yl]pyridin-2-yl}amino)-1,3-thiazol-5-yl]-N-(2,2,2-trifluoroethyl)nicotinamide;

N-(2-aminoethyl)-5-(2-{[4-(4,4-difluoropiperidin-1-yl)pyridin-2-yl]amino}-1,3-thiazol-5-yl)nicotinamide;

tert-butyl [(2E)-3-(5-{2-[(4-piperazin-1-ylpyridin-2-yl)amino]-1,3-thiazol-5-yl}pyridin-3-yl)prop-2-en-1-yl]carbamate;

N-{5-[5-(3-aminopropyl)pyridin-3-yl]-1,3-thiazol-2-yl}-4-morpholin-4-ylpyridin-2-amine;

tert-butyl [(2E)-3-(5-{2-[(4-morpholin-4-ylpyridin-2-yl)amino]-1,3-thiazol-5-yl}pyridin-3-yl)prop-2-en-1-yl]carbamate;

5-(2-{[4-(1,1-dioxidothiomorpholin-4-yl)pyridin-2-yl]amino}-1,3-thiazol-5-yl)-N-(2,2,2-trifluoroethyl)nicotinamide;

N-(5-{5-[(1E)-3-aminoprop-1-en-1-yl]pyridin-3-yl}-1,3-thiazol-2-yl)-4-morpholin-4-ylpyridin-2-amine;

4-(2-{[5-(5-{[(2,2,2-trifluoroethyl)amino]carbonyl}pyridin-3-yl)-1,3-thiazol-2-yl]amino}pyridin-4-yl)piperazine-1-carboxamide;

N-methyl-4-(2-{[5-(5-{[(2,2,2-trifluoroethyl)amino]carbonyl}pyridin-3-yl)-1,3-thiazol-2-yl]amino}pyridin-4-yl)piperazine-1-carboxamide;

butyl 5-(2-{[4-(4,4-difluoropiperidin-1-yl)pyridin-2-yl]amino}-1,3-thiazol-5-yl)nicotinate;

N-(2-fluoroethyl)-5-{2-[(4-morpholin-4-ylpyridin-2-yl)amino]-1,3-thiazol-5-yl}nicotinamide;

5-{2-[(4-morpholin-4-ylpyridin-2-yl)amino]-1,3-thiazol-5-yl}-N-(2,2,2-trifluoro-1-methylethyl)nicotinamide;

N-(2-aminoethyl)-5-{2-[(4-morpholin-4-ylpyridin-2-yl)amino]-1,3-thiazol-5-yl}pyridine-2-carboxamide;

methyl 5-{2-[(4-morpholin-4-ylpyridin-2-yl)amino]-1,3-thiazol-5-yl}pyridine-2-carboxylate;

5-(2-{[4-(4,4-difluoropiperidin-1-yl)pyridin-2-yl]amino}-1,3-thiazol-5-yl)-N-(2,2,2-trifluoroethyl)nicotinamide;

4-morpholin-4-yl-N-{5-[6-(morpholin-4-ylcarbonyl)pyridin-3-yl]-1,3-thiazol-2-yl}pyridin-2-amine;

5-{2-[(4-morpholin-4-ylpyridin-2-yl)amino]-1,3-thiazol-5-yl}pyridine-2-carboxylic acid;

N-(2-aminoethyl)-5-{2-[(4-chloropyridin-2-yl)amino]-1,3-thiazol-5-yl}pyridine-2-carboxamide;

5-(2-{[4-(4-fluoropiperidin-1-yl)pyridin-2-yl]amino}-1,3-thiazol-5-yl)-N-(2,2,2-trifluoroethyl)nicotinamide;

N-(3-aminopropyl)-5-{2-[(4-chloropyridin-2-yl)amino]-1,3-thiazol-5-yl}pyridine-2-carboxamide;

5-{2-[(4-piperidin-1-ylpyridin-2-yl)amino]-1,3-thiazol-5-yl}-N-(2,2,2-trifluoroethyl)nicotinamide;

4-morpholin-4-yl-N-{5-[5-(morpholin-4-ylcarbonyl)pyridin-3-yl]-1,3-thiazol-2-yl}pyridin-2-amine;

tert-butyl (3-{[(5-{2-[(4-morpholin-4-ylpyridin-2-yl)amino]-1,3-thiazol-5-yl}pyridin-3-yl)carbonyl]amino}propyl)carbamate;

N-(2-aminoethyl)-5-{2-[(3-chloropyridin-2-yl)amino]-1,3-thiazol-5-yl}nicotinamide;

5-{2-[(3-methylpyridin-2-yl)amino]-1,3-thiazol-5-yl}nicotinic acid;

N-(2-aminoethyl)-5-{2-[(3-methylpyridin-2-yl)amino]-1,3-thiazol-5-yl}nicotinamide;

5-{2-[(3-methylpyridin-2-yl)amino]-1,3-thiazol-5-yl}-N-(2,2,2-trifluoroethyl)nicotinamide;

5-{2-[(3-chloropyridin-2-yl)amino]-1,3-thiazol-5-yl}-N-(2,2,2-trifluoroethyl)nicotinamide;

N-(2-aminoethyl)-5-{2-[(4-chloropyridin-2-yl)amino]-1,3-thiazol-5-yl}nicotinamide;

5-{2-[(4,6-dimethylpyridin-2-yl)amino]-1,3-thiazol-5-yl}nicotinic acid;

5-{2-[(2-chlorophenyl)amino]-1,3-thiazol-5-yl}nicotinic acid;

5-{2-[(3-chlorophenyl)amino]-1,3-thiazol-5-yl}nicotinic acid;

N-(2-aminoethyl)-5-{2-[(4,6-dimethylpyridin-2-yl)amino]-1,3-thiazol-5-yl}nicotinamide;

N-(2-aminoethyl)-5-{2-[(3-chlorophenyl)amino]-1,3-thiazol-5-yl}nicotinamide;

N-(2-aminoethyl)-5-{2-[(2-chlorophenyl)amino]-1,3-thiazol-5-yl}nicotinamide;

N-(2-aminoethyl)-5-[2-(pyridin-2-ylamino)-1,3-thiazol-5-yl]nicotinamide;

N-(2-aminoethyl)-5-{2-[(4-methylpyridin-2-yl)amino]-1,3-thiazol-5-yl}nicotinamide;

N-(2-aminoethyl)-5-{2-[(4,6-dichloropyridin-2-yl)amino]-1,3-thiazol-5-yl}nicotinamide;

N-(2-aminoethyl)-5-(2-{[6-chloro-4-(trifluoromethyl)pyridin-2-yl]amino}-1,3-thiazol-5-yl)nicotinamide;

N-(2-aminoethyl)-5-{2-[(3-bromopyridin-2-yl)amino]-1,3-thiazol-5-yl}nicotinamide;

N-(2-aminoethyl)-5-(2-{[4-(dimethylamino)pyridin-2-yl]amino}-1,3-thiazol-5-yl)nicotinamide;

N-(2-aminoethyl)-5-[2-(quinolin-2-ylamino)-1,3-thiazol-5-yl]nicotinamide;

N-(2-aminoethyl)-5-[2-(isoquinolin-3-ylamino)-1,3-thiazol-5-yl]nicotinamide;

N-(2-aminoethyl)-5-[2-(isoquinolin-1-ylamino)-1,3-thiazol-5-yl]nicotinamide;

5-{2-[(3-methylquinolin-2-yl)amino]-1,3-thiazol-5-yl}-N-(2,2,2-trifluoroethyl)nicotinamide;

N-(2-aminoethyl)-5-{2-[(6-morpholin-4-ylpyrimidin-4-yl)amino]-1,3-thiazol-5-yl}nicotinamide;

5-{2-[(6-morpholin-4-ylpyrimidin-4-yl)amino]-1,3-thiazol-5-yl}-N-(2,2,2-trifluoroethyl)nicotinamide;

N-(2-aminoethyl)-5-{2-[(6-chloropyrimidin-4-yl)amino]-1,3-thiazol-5-yl}nicotinamide;

5-(2-{[6-(4,4-difluoropiperidin-1-yl)pyrimidin-4-yl]amino}-1,3-thiazol-5-yl)-N-(2,2,2-trifluoroethyl)nicotinamide;

5-{2-[(6-chloropyrimidin-4-yl)amino]-1,3-thiazol-5-yl}-N-(2,2,2-trifluoroethyl)nicotinamide;

N-(2-aminoethyl)-5-{2-[(5-methyl-6-morpholin-4-ylpyrimidin-4-yl)amino]-1,3-thiazol-5-yl}nicotinamide;

N-(2-aminoethyl)-5-(2-{[6-(4,4-difluoropiperidin-1-yl)-5-methylpyrimidin-4-yl]amino}-1,3-thiazol-5-yl)nicotinamide;

N-(2-aminoethyl)-5-{2-[(6-chloro-5-methylpyrimidin-4-yl)amino]-1,3-thiazol-5-yl}nicotinamide;

5-(2-{[6-(dimethylamino)pyrimidin-4-yl]amino}-1,3-thiazol-5-yl)-N-(2,2,2-trifluoroethyl)nicotinamide;

N-methyl-4-(6-{[5-(5-{[(2,2,2-trifluoroethyl)amino]carbonyl}pyridin-3-yl)-1,3-thiazol-2-yl]amino}pyrimidin-4-yl)piperazine-1-carboxamide;

5-[2-({6-[4-(methylsulfonyl)piperazin-1-yl]pyrimidin-4-yl}amino)-1,3-thiazol-5-yl]-N-(2,2,2-trifluoroethyl)nicotinamide;

5-{2-[(5-methyl-6-morpholin-4-ylpyrimidin-4-yl)amino]-1,3-thiazol-5-yl}-N-(2,2,2-trifluoroethyl)nicotinamide;

5-{2-[(6-chloro-5-methylpyrimidin-4-yl)amino]-1,3-thiazol-5-yl}-N-(2,2,2-trifluoroethyl)nicotinamide;

5-(2-{[6-(4,4-difluoropiperidin-1-yl)-5-methylpyrimidin-4-yl]amino}-1,3-thiazol-5-yl)-N-(2,2,2-trifluoroethyl)nicotinamide;

N-(2-aminoethyl)-5-[2-(pyrazin-2-ylamino)-1,3-thiazol-5-yl]nicotinamide;

N-(2-aminoethyl)-5-{2-[(3,5-dimethylpyrazin-2-yl)amino]-1,3-thiazol-5-yl}nicotinamide;

N-(2-aminoethyl)-5-{2-[(3-chloropyrazin-2-yl)amino]-1,3-thiazol-5-yl}nicotinamide;

5-(2-{[3-methyl-4-(morpholin-4-ylmethyl)pyridin-2-yl]amino}-1,3-thiazol-5-yl)-N-(2,2,2-trifluoroethyl)nicotinamide;

5-(2-{[4-(hydroxymethyl)-3-methylpyridin-2-yl]amino}-1,3-thiazol-5-yl)-N-(2,2,2-trifluoroethyl)nicotinamide;

N-(2-aminoethyl)-5-(2-{[3-(trifluoromethyl)pyridin-2-yl]amino}-1,3-thiazol-5-yl)nicotinamide;

5-{2-[(3-chloropyridin-2-yl)amino]-1,3-thiazol-5-yl}-N-methoxy-N-methylnicotinamide;

1-(5-{2-[(3-chloropyridin-2-yl)amino]-1,3-thiazol-5-yl}pyridin-3-yl)ethanone; and

3-(5-{2-[(4-morpholin-4-ylpyridin-2-yl)amino]-1,3-thiazol-5-yl}pyridin-3-yl)propan-1-ol;

or a pharmaceutically acceptable salt or a stereoisomer thereof.

4 . A pharmaceutical composition comprising a pharmaceutical carrier, and dispersed therein, a therapeutically effective amount of a compound of claim 1 .

5 . A method of treating cancer comprising the step of administering a therapeutically effective amount of the compound of claim 1 to a subject.

6 . (canceled)

Assignments (2)
CHANGE OF NAME Recorded Jan 26, 2010
From: MERCK & CO., INC.
To: MERCK SHARP & DOHME CORP.
Reel/Frame 023906/0803 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 7, 2009
From: HOFFMAN, JACOB M.; ARRINGTON, KENNETH L.; DUDKIN, VADIM Y.; FRALEY, MARK E.; KREATSOULAS, CONSTANTINE; WANG, CHENG
To: MERCK & CO., INC.
Reel/Frame 022650/0149 →